-+ 0.00%
-+ 0.00%
-+ 0.00%

Eupraxia Pharmaceuticals Q2 EPS $(0.23) Beats $(0.25) Estimate

Benzinga·08/11/2026 21:50:46
Listen to the news
Eupraxia Pharmaceuticals (TSX:EPRX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent. This is a 11.54 percent increase over losses of $(0.26) per share from the same period last year.